Meet the speakers


The Congress speaker faculty brings you the knowledge and experience of some of the best in the business. Check back for updates. If you'd like to join them get in touch with us today!

You can also review the Medtech Leaders and Healthtech Leaders


Biotech Leaders

Douglas Abrams, Managing Director, Expara

Douglas Abrams

Managing Director
Expara
Renée Aguiar-Lucander, CEO, Calliditas Therapeutics

Renée Aguiar-Lucander

CEO
Calliditas Therapeutics
Naseem Amin, CEO, gmp-orphan

Naseem Amin

CEO
gmp-orphan
Madeleine Armstrong, News Editor, Vantage

Madeleine Armstrong

News Editor
Vantage
Rhony Aufdenblatten, Head of Commercial Development, Combined Offerings Small Molecules Business Unit, Lonza Pharma & Biotech

Rhony Aufdenblatten

Head of Commercial Development
Lonza Pharma & Biotech
Christine Baker, CBO, Hookipa Pharma

Christine Baker

CBO
Hookipa Pharma
Sharon Benzeno, CBO, Adaptive Biotech

Sharon Benzeno

CBO
Adaptive Biotech
Caroline Barelle, Co-Founder and CEO, Elasmogen

Caroline Barelle

Co-Founder and CEO
Elasmogen
Liz Barrett, CEO, Urogen

Liz Barrett

CEO
Urogen
Jasper Bos, SVP and Managing Director, M Ventures

Jasper Bos

SVP and Managing Director
M Ventures
Samana Brannigan, Innovation Lead and Investor Relations, Innovate UK

Samana Brannigan

Innovation Lead and Investor Relations
Innovate UK
Matt Cardinal, Principal, Halloran Consulting Group

Matt Cardinal

Principal
Halloran Consulting Group
Helene Casaert, Regulatory Science and Innovation Task force, SME office, European Medicines Agency

Helene Casaert

Regulatory Science and Innovation Task force, SME office
European Medicines Agency
John Cassidy, Principal, Arix Bioscience

John Cassidy

Principal
Arix Bioscience
Neil Clark, CEO, Destiny Pharma 300x

Neil Clark

CEO
Destiny Pharma
Yuehua Cong, Executive Director, Head of Europe, Simcere Pharmaceutical Group

Yuehua Cong

Executive Director, Head of Europe
Simcere Pharmaceutical Group
Clive Cookson, Science Editor, Financial Times

Clive Cookson

Science Editor
Financial Times
Laia Crespo, Head of Europe, Sanofi Ventures

Laia Crespo

Head of Europe
Sanofi Ventures
Sharon Cunningham, Co-Founder and CEO, Shorla Pharma

Sharon Cunningham

Co-Founder and CEO
Shorla Pharma
Maria Dahl, COO and Head of Europe, Innovent Bio

Maria Dahl

COO and Head of Europe
Innovent Bio
Darrin Disley, CEO, Mogrify

Darrin Disley

CEO
Mogrify
Jason Duncan, Chief Legal Officer and General Counsel, Albireo

Jason Duncan

Chief Legal Officer and General Counsel
Albireo
Jürg Eckhardt, SVP and Head of Leaps by Bayer, Bayer

Jürg Eckhardt

SVP and Head of Leaps by Bayer
Bayer
Lucie Ellis, Executive Editor, In Vivo

Lucie Ellis

Executive Editor
In Vivo
Carl Engleman, Vice President, Cello Health Consulting

Carl Engleman

Vice President
Cello Health Consulting
Johnston Erwin, VP Corporate Business Development, Eli Lilly

Johnston Erwin

VP Corporate Business Development
Eli Lilly
Ted Fjällman, CEO, Prokarium

Ted Fjällman

CEO
Prokarium
Beth Fordham-Meier, VP Business Development, Cello Health BioConsulting

Beth Fordham-Meier

VP BD & Head, Partnering Strategy Practice
Cello Health BioConsulting
Eliot Forster, CEO, F-star Therapeutics

Eliot Forster

CEO
F-star Therapeutics
Jason Foster, CEO, Ori Biotech

Jason Foster

CEO
Ori Biotech
Miriam Frieden, Vice President S&E, Novo Nordisk

Miriam Frieden

Vice President S&E
Novo Nordisk
Matthew Gline, CFO, Roivant

Matthew Gline

CFO
Roivant
Alex Hamilton, Partner, Syncona

Alex Hamilton

Partner
Syncona
Bill Hicks, Co-chair Securities & Capital Markets Group, Mintz

Bill Hicks

Co-chair Securities & Capital Markets Group
Mintz
Regina Hodits, Managing Partner, Wellington Partner

Regina Hodits

Managing Partner
Wellington Partners
Ben Hohn, Principal - Launch, BD, Pipeline and Product Development Strategy, ZS

Ben Hohn

Principal - BD, Pipeline and Launch Strategy
ZS
Adam Houghton, VP and Head, AbbVie Ventures

Adam Houghton

VP and Head
AbbVie Ventures
Nick Ibery, General Partner, NCL Technology Ventures

Nick Ibery

General Partner
NCL Technology Ventures
Shu Joshi, Managing Partner, LSV Capital and & Co-Chair of Global Investment Committee, Xhealth Innovation Labs

Shu Joshi

Managing Partner, LSV Capital
Co-Chair of Global Investment Committee, Xhealth Innovation Labs
Wouter Joustra, General Partner, Forbion

Wouter Joustra

General Partner
Forbion
Ed Kaye, CEO, Stoke Therapeutics

Ed Kaye

CEO
Stoke Therapeutics
Adam Keeney, CEO, NodThera

Adam Keeney

CEO
NodThera
Adam Kostyal, SVP, Nasdaq

Adam Kostyal

SVP
Nasdaq
Cornelia Kroeger, Senior Consultant, Halloran Consulting Group

Cornelia Kroeger

Senior Consultant
Halloran Consulting Group
Axel Kullick, Manager International Market Development, Invest Region Leipzig 300x

Axel Kullick

Manager International Market Development
Invest Region Leipzig
Phil L’Huillier, Head of BD, Europe, European Innovation Hub, MSD

Phil L’Huillier

Head of BD, Europe, European Innovation Hub
MSD
Teresa Lavoie, Principal, Fish & Richardson

Teresa Lavoie

Principal
Fish & Richardson
Philippe Lopes-Fernandes, EVP & CBO, Ipsen

Philippe Lopes-Fernandes

EVP & CBO
Ipsen
Tim Luker, VP Lilly New Ventures and Emerging Technology, Eli Lilly

Tim Luker

VP Lilly New Ventures and Emerging Technology
Eli Lilly
Nanna Lüneborg, Partner, Novo Ventures

Nanna Lüneborg

Partner
Novo Ventures
Fiona MacLaughlin, Senior Director, Johnson & Johnson Innovation JJDC Inc

Fiona MacLaughlin

Senior Director
, Johnson & Johnson Innovation JJDC Inc
Sean Marett, CBO, BioNTech

Sean Marett

CBO
BioNTech
Jan Mattsson, Chief Scientific Officer and Co-Founder, Albireo

Jan Mattsson

Chief Scientific Officer and Co-Founder
Albireo
Robbie McLaren, Partner, Latham & Watkins

Robbie McLaren

Partner
Latham & Watkins
Elizabeth Mily, EVP BD, BMS

Elizabeth Mily

EVP BD
BMS
Su-Peing Ng, VP Global Medical Head, COVID-19 Vaccines Taskforce Leader, Sanofi Pasteur

Su-Peing Ng

VP Global Medical Head, COVID-19 Vaccines Taskforce Leader
Sanofi Pasteur
Susanna Obad, Global Business Development Director, Roche Partnering

Susanna Obad

Global Business Development Director
Roche Partnering
Andrey Ostrovsky, Former Chief Medical Officer of US Medicaid Program, Managing Partner, Social Innovation Ventures

Andrey Ostrovsky

Former Chief Medical Officer of US Medicaid Program
Managing Partner, Social Innovation Ventures
Andrew Parratt, VP Commercial Planning and Operations, Karuna Therapeutics

Andrew Parratt

VP Commercial Planning and Operations
Karuna Therapeutics
Steven Powell, CEO, eTheRNA

Steven Powell

CEO
eTheRNA
Cody Powers, Principal Strategy & Advisory, ZS Associates

Cody Powers

Principal Strategy & Advisory
ZS Associates
Aditya Puri, Partner Investments, Xeraya Capital

Aditya Puri

Partner Investments
Xeraya Capital
Frank Rahmani, Partner, Sidley Austin

Frank Rahmani

Partner
Sidley Austin
Thom Rasche, Managing Partner, Earlybird Capital

Thom Rasche

Managing Partner
Earlybird Capital
Kieran Rooney, VP, Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP, Strategic Alliances and Licensing
Amryt Pharma
Thibaut Roulon, Investment Director, BpiFrance

Thibaut Roulon

Investment Director
BpiFrance
Ed Saltzman, Executive Chairman, Cello Health BioConsulting

Ed Saltzman

Executive Chairman
Cello Health BioConsulting
Jorge Santos da Silva, Partner, McKinsey & Company

Jorge Santos da Silva

Partner
McKinsey & Company
Aradhana Sarin, CFO, Alexion Pharmaceuticals

Aradhana Sarin

CFO
Alexion Pharmaceuticals
Hans Schambye, CEO, Galecto

Hans Schambye

CEO
Galecto
Mirko Scherer, CEO, CoFeS China

Mirko Scherer

CEO
CoFeS China
Denise Scots Knight, CEO, Mereo BioPharma

Denise Scots Knight

CEO
Mereo BioPharma
Sara Secall, Partner, Inveready

Sara Secall

Partner
INVEready
Stephanie Sirota, Partner and Chief Business Officer, RTW Investments

Stephanie Sirota

Partner and Chief Business Officer
RTW Investments
Yochi Slonim, CEO, Anima Biotech

Yochi Slonim

CEO
Anima Biotech
Laurie Smaldone Alsup, CSO/CMO, NDA Group

Laurie Smaldone Alsup

CSO/CMO
NDA Group
Steffen Thirstrup, Former Chief Medical Officer, Danish Medicines agency and Director, NDA Regulatory Advisory Board, NDA Group

Steffen Thirstrup

Former Chief Medical Officer, Danish Medicines Agency
Director, NDA Regulatory Advisory Board, NDA Group
Ben Thorner, SVP and Head MRL Business Development & Licensing, Merck & Co

Ben Thorner

SVP and Head MRL Business Development & Licensing
Merck & Co
Thomas Tradler, Head of BD, Fraunhofer Institute for Cell Therapy and Immunology

Thomas Tradler

Head of BD
Fraunhofer Institute for Cell Therapy and Immunology
Angela Tyrell, SVP, Longevity Leaders

Angela Tyrell

SVP
Longevity Leaders
Erik van den Berg, CEO, AM-Pharma

Erik van den Berg

CEO
AM-Pharma
Valerie Vanhooren, CEO, ONA Therapeutics

Valerie Vanhooren

Co-Founder and CEO
ONA Therapeutics
Edward van Wezel, Managing Partner, Biogeneraiton Ventures

Edward van Wezel

Managing Partner
Biogeneraiton Ventures
Guillaume Vignon, SVP BD, Beigene

Guillaume Vignon

SVP BD
Beigene
Monika Vnuk, VP Worldwide Business Development, Pfizer

Monika Vnuk

VP Worldwide Business Development
Pfizer
Lea von Bidder, CEO & Co-founder, Ava

Lea von Bidder

CEO & Co-founder
Ava
Barbara Weigert, Project Manager Inward Investment, Saxony Economic Development Corporation

Barbara Weigert

Project Manager Inward Investment
Saxony Economic Development Corporation
Brian Yang, Senior Writer & China Head, Scrip

Brian Yang

Senior Writer & China Head
Scrip
Jay Yin, Partner, Bioventure

Jay Yin

Partner
Bioventure
Chen Yu, Managing Partner, TCG Crossover Fund

Chen Yu

Managing Partner
TCG Crossover Fund
Constantinos Ziogas, Head of SME Office, European Medicines Agency

Constantinos Ziogas

Head of SME Office
European Medicines Agency
DOWNLOAD BROCHURE